Strategies for Prolonged Therapy in Patients With Advanced Non-Small-Cell Lung CancerFIDIAS, Panos; NOVELLO, Silvia.Journal of clinical oncology. 2010, Vol 28, Num 34, pp 5116-5123, issn 0732-183X, 8 p.Article

Case 17-2014: A 64-Year-Old Man with Chest Pain and a Pleural EffusionKRADIN, Richard L; FIDIAS, Panos; DIGUMARTHY, Subba et al.The New England journal of medicine. 2014, Vol 370, Num 22, pp 2132-2140, issn 0028-4793, 9 p.Article

A 43-year-old woman with painful nodules on the fingertips, shortness of breath, and fatigueCOSTENBADER, Karen H; FIDIAS, Panos; GILMAN, Matthew D et al.The New England journal of medicine. 2006, Vol 355, Num 12, pp 1263-1272, issn 0028-4793, 10 p.Article

Radiation dose escalation in limited-stage small-cell lung cancerROOF, Kevin S; FIDIAS, Panos; LYNCH, Thomas J et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 3, pp 701-708, issn 0360-3016, 8 p.Article

Epidermal growth factor receptor mutation testing in the care of lung cancer patientsSEQUIST, Lecia V; JOSHI, Victoria A; VERLANDER, Peter et al.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4403s-4408s, 2Conference Paper

A man with a mediastinal massWRIGHT, Cameron D; FIDIAS, Panos; CHOI, Noah C. H et al.The New England journal of medicine. 2007, Vol 356, Num 21, pp 2185-2193, issn 0028-4793, 9 p.Article

Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life : A randomized controlled trialBELANI, Chandra P; PEREIRA, Jose R; MILLWARD, Michael et al.Lung cancer. 2006, Vol 53, Num 2, pp 231-239, issn 0169-5002, 9 p.Article

Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung CancerKWAK, Eunice L; BANG, Yung-Jue; VARELLA-GARCIA, Marileila et al.The New England journal of medicine. 2010, Vol 363, Num 18, pp 1693-1703, issn 0028-4793, 11 p.Article

Erlotinib Plus Bevacizumab in Previously Treated Patients With Malignant Pleural MesotheliomaJACKMAN, David M; KINDLER, Hedy L; YEAP, Beow Y et al.Cancer. 2008, Vol 113, Num 4, pp 808-814, issn 0008-543X, 7 p.Article

A phase II study of weekly Paclitaxel in elderly patients with advanced non-small cell lung cancerFIDIAS, Panos; SUPKO, Jeffrey G; SKARIN, Arthur et al.Clinical cancer research. 2001, Vol 7, Num 12, pp 3942-3949, issn 1078-0432Article

A Rapid Outcomes Ascertainment System Improves the Quality of Prognostic and Pharmacogenetic Outcomes from Observational StudiesBRADBURY, Penelope A; SUK HEIST, Rebecca; SEQUIST, Lecia et al.Cancer epidemiology, biomarkers & prevention. 2008, Vol 17, Num 1, pp 204-211, issn 1055-9965, 8 p.Article

Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancerFANUCCHI, Michael P; FOSSELLA, Frank V; AKERLEY, Wallace et al.Journal of clinical oncology. 2006, Vol 24, Num 31, pp 5025-5033, issn 0732-183X, 9 p.Article

Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancerCHOI, Noah C; FISCHMAN, Alan J; NIEMIERKO, Andrzej et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 4, pp 1024-1035, issn 0360-3016, 12 p.Article

Induction Chemoradiotherapy Followed by Resection for Locally Advanced Masaoka Stage III and IVA Thymic Tumors. CommentaryHUANG, James; RIELY, Gregory J; ROSENZWEIG, Kenneth E et al.The Annals of thoracic surgery. 2008, Vol 85, Num 2, issn 0003-4975, 365-367, 385-389 [8 p.]Article

Phase II study : Integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patientsTEMEL, Jennifer S; JACKSON, Vicki A; PIRL, William F et al.Journal of clinical oncology. 2007, Vol 25, Num 17, pp 2377-2382, issn 0732-183X, 6 p.Article

Phase ii clinical trial of chemotherapy-naive patients ≥ 70 years of age treated with erlotinib for advanced non-small-cell lung cancerJACKMAN, David M; YEAP, Beow Y; FREIDLIN, Boris et al.Journal of clinical oncology. 2007, Vol 25, Num 7, pp 760-766, issn 0732-183X, 7 p.Article

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, 'Iressa') on an expanded access studyJÄNNE, Pasi A; GURUBHAGAVATULA, Sarada; YEAP, Beow Y et al.Lung cancer. 2004, Vol 44, Num 2, pp 221-230, issn 0169-5002, 10 p.Article

Phase II Trial of Pemetrexed and Gemcitabine in Chemotherapy-Naive Malignant Pleural MesotheliomaJÄNNE, Pasi A; SIMON, George R; LANGER, Corey J et al.Journal of clinical oncology. 2008, Vol 26, Num 9, pp 1465-1471, issn 0732-183X, 7 p.Article

Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: A Phase I studyWIRTH, Lori J; LUCCA, Joan; LUKANICH, Jeanne M et al.Clinical cancer research. 2003, Vol 9, Num 5, pp 1698-1704, issn 1078-0432, 7 p.Article

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinomaSALGIA, Ravi; LYNCH, Thomas; LUKANICH, Jean et al.Journal of clinical oncology. 2003, Vol 21, Num 4, pp 624-630, issn 0732-183X, 7 p.Article

Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non-Small-Cell Lung CancerFIDIAS, Panos M; DAKHIL, Shaker R; MARCINIAK, Martin et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 591-598, issn 0732-183X, 8 p.Conference Paper